FIT Biotech Oy : FIT Biotech Oy’s Annual Report 2015 published – FIT Biotech

Reports and Releases

FIT Biotech Oy : FIT Biotech Oy’s Annual Report 2015 published

Company announcement
March 18, 2016 at 10.00 am

FIT Biotech Oy's Annual Report 2015 published

The Finnish version of FIT Biotech Oy's Annual Report for the year 2015 has been published today. The English version of the Annual Report will be published on Tuesday, March 22, 2016. Annual Report contains the financial statements and the report of the Board of Directors.


Board of Directors

Further information:

Rabbe Slätis
CEO, FIT Biotech Oy
Tel.: +358 40 840 6749

Certified Advisor: Translink Corporate Finance Oy, tel. +358 20 743 2790

FIT Biotech in brief

FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.
FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland market maintained by Nasdaq Helsinki Oy.


Principal media

Back to list